Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Frontiers in Immunology|February 9, 2024
Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two casesChiho Furuya, Hajime Yasuda, Makoto Hiki, et al.British Journal of Haematology|November 3, 2023
Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patientsChiho Furuya, Soji Morishita, Yoshinori Hashimoto, et al.Hematology (Amsterdam, Netherlands)|June 28, 2023
MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in JapanChiho Furuya, Yoshinori Hashimoto, Soji Morishita, et al.Hematology (Amsterdam, Netherlands)|January 24, 2022
Validation and reliability of current guidelines for the treatment of essential thrombocythemia under real-world clinical settings in JapanTerumi Baba, Yoshinori Hashimoto, Hajime Yasuda, et al.Journal of Thrombosis and Thrombolysis|December 9, 2022
Reevaluation of cardiovascular risk factors for thrombotic events in 580 Japanese patients with essential thrombocythemiaChiho Furuya, Yoshinori Hashimoto, Soji Morishita, et al.International Journal of Hematology|August 29, 2018
Dasatinib-induced anti-leukemia cellular immunity through a novel subset of CD57 positive helper/cytotoxic CD4 T cells in chronic myelogenous leukemia patientsNaoki Watanabe, Tomoiku Takaku, Kazuyoshi Takeda, et al.Hematology (Amsterdam, Netherlands)|November 15, 2024
A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia veraChiho Furuya, Yoshinori Hashimoto, Soji Morishita, et al.Leukemia Research Reports|June 17, 2021
Intravascular large B-cell lymphoma as a recurrence of primary central nervous system lymphoma after chemotherapy: A case reportYoko Edahiro, Tomoiku Takaku, Mario Suzuki, et al.International Journal of Hematology|December 20, 2014
Consequences of the JAK2V617F allele burden for the prediction of transformation into myelofibrosis from polycythemia vera and essential thrombocythemiaShuichi Shirane, Marito Araki, Soji Morishita, et al.European Journal of Haematology|October 8, 2022
Non-driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemiaSoji Morishita, Yoshinori Hashimoto, Chiho Furuya, et al.Pageof 5